This company has been marked as potentially delisted and may not be actively trading. Can B (CANB) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock CANB vs. MEDS, BIMI, CERO, XWEL, PBM, NKGN, TTNP, SXTP, NRBO, and MOVEShould you be buying Can B stock or one of its competitors? The main competitors of Can B include TRxADE HEALTH (MEDS), BIMI (BIMI), CERo Therapeutics (CERO), XWELL (XWEL), Psyence Biomedical (PBM), NKGen Biotech (NKGN), Titan Pharmaceuticals (TTNP), 60 Degrees Pharmaceuticals (SXTP), NeuroBo Pharmaceuticals (NRBO), and Movano (MOVE). These companies are all part of the "medical" sector. Can B vs. Its Competitors TRxADE HEALTH BIMI CERo Therapeutics XWELL Psyence Biomedical NKGen Biotech Titan Pharmaceuticals 60 Degrees Pharmaceuticals NeuroBo Pharmaceuticals Movano Can B (NASDAQ:CANB) and TRxADE HEALTH (NASDAQ:MEDS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership. Does the media favor CANB or MEDS? In the previous week, TRxADE HEALTH's average media sentiment score of 0.00 beat Can B's score of -0.14 indicating that TRxADE HEALTH is being referred to more favorably in the news media. Company Overall Sentiment Can B Neutral TRxADE HEALTH Neutral Which has more risk & volatility, CANB or MEDS? Can B has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Comparatively, TRxADE HEALTH has a beta of 2.32, meaning that its share price is 132% more volatile than the S&P 500. Which has stronger valuation & earnings, CANB or MEDS? Can B has higher earnings, but lower revenue than TRxADE HEALTH. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCan B$2.16M0.69-$9.74MN/AN/ATRxADE HEALTH$7.45M0.18-$17.84MN/AN/A Is CANB or MEDS more profitable? TRxADE HEALTH has a net margin of -149.81% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat TRxADE HEALTH's return on equity.Company Net Margins Return on Equity Return on Assets Can B-1,238.33% N/A -218.65% TRxADE HEALTH -149.81%-196.79%-112.21% Do institutionals & insiders hold more shares of CANB or MEDS? 6.1% of Can B shares are owned by institutional investors. Comparatively, 5.7% of TRxADE HEALTH shares are owned by institutional investors. 11.4% of Can B shares are owned by insiders. Comparatively, 48.4% of TRxADE HEALTH shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryTRxADE HEALTH beats Can B on 6 of the 10 factors compared between the two stocks. Get Can B News Delivered to You Automatically Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CANB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CANB vs. The Competition Export to ExcelMetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.49M$2.43M$5.84B$10.14BDividend YieldN/AN/A5.68%4.60%P/E RatioN/AN/A75.4125.98Price / Sales0.690.18515.81181.13Price / CashN/AN/A37.5660.44Price / Book-0.062.1012.156.29Net Income-$9.74M-$17.84M$3.29B$271.07M Can B Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CANBCan BN/A$0.02-1.1%N/A+72.4%$1.49M$2.16M0.0016MEDSTRxADE HEALTHN/A$0.89+0.3%N/A-87.1%$1.25M$7.45M0.0050BIMIBIMIN/A$0.00flatN/AN/A$1K$12.63M0.00520CEROCERo Therapeutics3.563 of 5 stars$5.50+10.2%$45.00+718.2%-97.1%$6.01MN/A0.008XWELXWELL0.7721 of 5 stars$1.05+1.0%N/A-31.7%$5.99M$33.90M-0.26360News CoveragePositive NewsShort Interest ↑Gap UpPBMPsyence Biomedical0.703 of 5 stars$3.24+1.6%N/A-96.1%$5.96MN/A0.00N/APositive NewsGap UpNKGNNKGen Biotech0.1387 of 5 stars$0.13-7.0%N/A-82.9%$5.96MN/A-0.03N/ATTNPTitan Pharmaceuticals0.1443 of 5 stars$4.27-4.0%N/A-24.3%$5.92MN/A-1.4510Positive NewsShort Interest ↓SXTP60 Degrees Pharmaceuticals2.3631 of 5 stars$1.42-0.7%$3.00+111.3%-79.7%$5.87M$641.41K-0.033Positive NewsNRBONeuroBo PharmaceuticalsN/A$0.68+0.1%N/A-80.7%$5.85MN/A0.0010Gap UpMOVEMovano0.6601 of 5 stars$0.77+10.3%N/A-84.6%$5.82M$1.01M-0.1930Trending NewsUpcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies MEDS Competitors BIMI Competitors CERO Competitors XWEL Competitors PBM Competitors NKGN Competitors TTNP Competitors SXTP Competitors NRBO Competitors MOVE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CANB) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can B Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
